New Strategy Improves Pancreas/Kidney Recipients' Survival

May 09, 1997

Abandoning a standard drug treatment strategy used at most other transplant programs, surgeons at the UPMC were able to achieve higher-than-average patient and graft survival rates in recipients of combined pancreas and kidney transplants. Results of 92 cases are being presented by Robert Corry, M.D., professor of surgery at the Thomas E. Starzl Transplantation Institute May 16 at the ASTS scientific meeting.

In order to control rejection, many surgeons customarily prescribe kidney/pancreas recipients a drug cocktail of anti-rejection drugs plus a 10-14-day preparation of a potent serum that wipes out white blood cells in the immune system. The UPMC team did not use the serum, known as anti-lymphocyte induction therapy, and instead relied on tacrolimus, or Prograf, as its main line of defense against rejection.

Survival among the 92 patients who underwent combined kidney and pancreas transplants at the UPMC since July 1994 was 98 percent; graft survival of the kidney and pancreas was 94 and 85 percent, respectively. According to the International Pancreas Transplant Registry, 1994-95 one-year patient survival rates are 91 percent in recipients of kidney/pancreas transplants and pancreas graft survival is 80 percent.

Dr. Corry says graft survival at the UPMC has improved in part due to a novel surgical technique developed at the UPMC that protects the pancreas from injury as it is being removed from the donor and during its transport to the transplant center. Surgeons remove the pancreas, which is among the most frail of organs, as a parcel with the liver; the kidneys are removed in a separate surgical procedure. After the organs are transported to the transplant center hospital, the pancreas and liver are carefully dissected from each other. Typically, the liver is transplanted in one patient, and the pancreas, with or without one of the kidneys, is transplanted in another patient.


University of Pittsburgh Medical Center

Related Kidney Transplants Articles from Brightsurf:

COVID-19 in patients who have received kidney transplants or are undergoing dialysis
A recent study found that most kidney transplant recipients with COVID-19 do not need to be hospitalized.

Kidney transplants: Better results can be inferred from a larger number of cases
Kidney transplants: Better results can be derived with larger numbers of cases.

Robotic transplants safe for kidney disease patients with obesity
Researchers report that among patients with obesity, robotic kidney transplants produce survival outcomes comparable to those seen among nonobese patients.

Identical twin kidney transplants warrant gene sequencing, researchers say
Using US transplant registry data, clinical researchers at the University of Pittsburgh found that kidney transplants between identical twins have high success rates, but also surprisingly high rates of immunosuppressant use.

Kidney transplants from donors with HCV safe and functional 1 year post-transplantation
There has been a substantial increase in the number of transplants using HCV-infected kidneys across the United States.

Is ownership of dialysis facilities associated with access to kidney transplants?
An analysis that included data for nearly 1.5 million patients with end-stage kidney disease looked at whether ownership of dialysis facilities was associated with patients' access to kidney transplants.

Kidney transplants covered by Medicaid increased in states after Medicaid expansion
Medicaid expansion has helped more young, low-income adults with advanced kidney disease to avoid the costs and poor quality-of-life associated with dialysis, reports a study from researchers at Drexel University College of Medicine and the Dornsife School of Public Health at Drexel.

Genomic collision may explain why many kidney transplants fail
Up to 1 in 7 kidney donors and recipients may have a type of genetic incompatibility that leads to organ rejection, researchers at Columbia University have found.

Racial disparities persist in access to kidney transplants
In a new study of patients awaiting kidney transplants, Yale researchers found significant racial disparities.

Racial disparities, access to kidney transplants after new organ allocation system
Among the priorities of a new Kidney Allocation System implemented in 2014 was to improve access to transplants to underserved populations.

Read More: Kidney Transplants News and Kidney Transplants Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to